Patient Discovery Appoints Theresa West as Chief Commercial Officer

Patient Discovery Solutions appointed Theresa West as Chief Commercial Officer on May 17, 2021, aiming to enhance commercialization efforts in healthcare technology.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Very Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Patient Discovery Solutions appointed Theresa West as Chief Commercial Officer on May 17, 2021, aiming to enhance commercialization efforts in healthcare technology. With over 20 years of experience, including significant roles at Signify Health and Abbott Laboratories, West's leadership is expected to drive growth across healthcare systems, insurers, and pharmaceuticals. Jason Shore, CEO, highlighted West's commercial talent as crucial for accelerating the company's expansion and achieving its mission to transform patient care through real-world data insights.

Positive

Theresa West's appointment expected to enhance commercialization efforts.
West has a proven track record, increasing sales to $15MM at Signify Health.
Her leadership could accelerate growth across healthcare systems and pharma.

Negative

None.

Argus Session date unavailable

-0.23% session move Open Argus

Details

News Market Reaction – SGFY

The recorded move for SGFY in the trading session of this news was -0.23%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

05/17/2021 - 09:30 AM

BOSTON, May 17, 2021 /PRNewswire/ -- Patient Discovery Solutions, a leader in patient-provider engagement technologies which harness the power of real-world data to achieve better health outcomes, today announced the appointment of Theresa West to the position of Chief Commercial Officer. In this newly created role, Ms. West will lead all aspects of Patient Discovery's commercialization efforts, leveraging more than 20 years of healthcare technology experience, encompassing sales, marketing and new product launches.

"We are extremely pleased to welcome Theresa to Patient Discovery, and we look forward to having her accelerate and expand our growth across healthcare systems, insurers and pharma," said Jason Shore, Chief Executive and Co-Founder of Patient Discovery. "Our goal is to build Patient Discovery into one of the next great healthcare technology companies and the addition of best-in-class commercial talent is a key ingredient."

Ms. West brings extensive leadership experience to the role of Chief Commercial Officer at Patient Discovery Solutions. She previously served as National Vice President, Community Strategy and Solutions at Signify Health (NYSE: SGFY) which acquired TAVHealth, where she grew annual sales from a bootstrapped start-up to $15MM in annual sales in 5 years. Prior to TAVHealth, Ms. West held leadership roles at Abbot Laboratories and McKesson Corporation.

"The team at Patient Discovery shares a commitment to delivering an exceptional care experience while also having a profound impact on health outcomes," commented Ms. West. "I look forward to leading Patient Discovery's commercial organization as we accelerate growth with innovative technologies at the heart of solving some of the most important problems in healthcare."

About Patient Discovery

Patient Discovery's mission is to transform the way all patients are understood, supported and treated, and provide a platform for patients' real-world experiences to be integrated into decision-making throughout the entire healthcare ecosystem.

Our patient-provider engagement platform brings to the forefront non-clinical factors that both allow providers to efficiently create better patient-centric and standard care plans, and enable health systems, pharma, and payers to effectively make informed decisions based on aggregated, real-world patient insights.

For more information, please visit the company's website at www.patientdiscovery.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/patient-discovery-appoints-theresa-west-as-chief-commercial-officer-301292552.html

SOURCE Patient Discovery

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the significance of Theresa West's appointment at Patient Discovery Solutions?

Theresa West's appointment as Chief Commercial Officer is significant as it aims to enhance the company's commercialization efforts and drive growth in healthcare technology.

What experience does Theresa West bring to Patient Discovery Solutions?

Theresa West brings over 20 years of healthcare technology experience, including leadership roles at Signify Health and Abbott Laboratories.

How does Theresa West's previous experience impact her role at Patient Discovery?

Her successful track record of growing sales to $15MM at Signify Health positions her to effectively lead and expand Patient Discovery's commercial initiatives.

What are Patient Discovery Solutions' goals with the new Chief Commercial Officer?

The goals include accelerating and expanding growth across healthcare systems, insurers, and pharma, as part of a broader mission to transform patient care.

Patient Discovery Appoints Theresa West as Chief Commercial Officer